Home
News
Videos
Podcasts
Slides
Topics
Conferences
- SCAI 2018
- ACC 2018
- AHA 2017
- ESC 2017
- SCAI 2017
- ACC 2017

Search

Home
- Who We Are
- Resources
- Art
News
Videos
Podcasts
Slides
Topics
Conferences
- SCAI 2018
- ACC 2018
- AHA 2017
- ESC 2017
- SCAI 2017
- ACC 2017

Follow US

ACC 2018 Acute Coronary Syndrome Conferences

PHARMACLO: A Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Acute Coronary Syndrome

Last updated: April 22, 2018 4:02 pm

Sadaf Sharfaei, M.D.

Share

0 Min Read

SHARE

Dr. Ardissino and Dr. Gibson Discuss

Subscribe on iTunes or Google Play.

TAGGED:ACC 2018 Conference Featured

Share This Article

Facebook Copy Link Print

Leave a Comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Archives

Archives

Search

Search for:

Categories

Meta

Log in
Entries feed
Comments feed
WordPress.org

You Might Also Like

ACC 2021 Covid-19 News

ACTION-Coalition Trial: Therapeutic Dose of Anticoagulation Is Associated With Increased Risk of Bleeding and No Improvement in Clinical Outcomes Among Hospitalized COVID-19 Patients With Elevated D-Dimer Levels

May 18, 2021

Topical TXA Does Not Reduce Peri-Operative Seizures but Increases Risk of Transfusion in Cardiac Surgery Compared to Intravenous TXA

April 10, 2024

AUGUSTUS Trial: Dual Therapy with P2Y12 Inhibitor and Apixaban Safer Than Triple Therapy or Dual Therapy with Warfarin in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention

September 28, 2019

BETTER CARE-HF: EHR-embedded alert increased MRA prescription in AMBULATORY HFrEF patients

March 5, 2023

Enter the copyright text you want to display in the footer section

Contact
Blog
Complaint
Advertise

Welcome Back!

Sign in to your account

Username or Email Address

Password

Remember me

Lost your password?